Trials / Unknown
UnknownNCT05057104
Non-inferiority Study of Unresectable Hepatocelluar Carcinoma Receiving Stereotactic Radiotherapy Combined With Hepatic Arterial Chemoembolization Compared With Conversion Hepatectomy
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 320 (estimated)
- Sponsor
- Beijing 302 Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To compare the prognosis and adverse reactions of unresectable hepatocellular carcinoma receiving stereotactic radiotherapy combined with hepatic arterial chemoembolization and conversion hepatectomy
Conditions
Timeline
- Start date
- 2021-10-10
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
- First posted
- 2021-09-27
- Last updated
- 2021-09-27
Source: ClinicalTrials.gov record NCT05057104. Inclusion in this directory is not an endorsement.